What does systemic anticancer therapy (SACT) refer to?
Treatment of cancer using drugs that act throughout the body to destroy or control malignant cells.
What are the four main classes of systemic anticancer therapy?
How do cytotoxic drugs generally work?
By damaging DNA and triggering programmed cell death (apoptosis).
What are the four main clinical uses of chemotherapy?
What is the goal of adjuvant chemotherapy?
To eliminate micrometastatic disease post-surgery and improve survival (e.g. in breast, lung, colorectal cancers).
What is the goal of neoadjuvant chemotherapy?
To downstage a tumour before surgery (e.g. in oesophageal or rectal cancers).
When is curative chemotherapy used?
As the primary treatment in potentially curable cancers such as testicular tumours, lymphomas, leukaemias, and many paediatric malignancies.
What is the role of palliative chemotherapy?
To improve symptoms, enhance quality of life, and modestly prolong survival (e.g. in small cell lung cancer).
What are the two broad categories of chemotherapy toxicities?
List examples of acute toxicities.
List examples of late toxicities.
What is myelosuppression?
Suppression of bone marrow function leading to decreased production of red cells, white cells, and platelets.
What are the clinical effects of red cell suppression?
Lethargy and dyspnoea (from anaemia).
What are the effects of white cell suppression?
Increased susceptibility to infections (neutropenia).
What are the effects of platelet suppression?
Purpura and bleeding due to thrombocytopenia.
What types of infections are seen in chemotherapy patients?
Define febrile neutropenia.
Neutrophil count <1.0 × 10⁹/L and temperature >38°C.
How is neutropenic sepsis managed?
What is mucositis?
Inflammation and ulceration of the mucous membranes (oral, GI) due to chemotherapy-induced epithelial damage.
What are the three types of CINV?
What has reduced the occurrence of anticipatory emesis?
Improved use of modern antiemetic regimens.
Name high-risk drugs for chemotherapy-induced emesis.
Cisplatin, dacarbazine, doxorubicin, epirubicin, ifosfamide, streptozocin.
Name moderate-risk drugs for emesis.
Cyclophosphamide and carboplatin
Name low-risk drugs for emesis.
Methotrexate, 5-fluorouracil, taxanes, topotecan.